IBDEI0Z9 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15731,0)
 ;;=B35.4^^88^869^320
 ;;^UTILITY(U,$J,358.3,15731,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15731,1,3,0)
 ;;=3^Tinea Corporis
 ;;^UTILITY(U,$J,358.3,15731,1,4,0)
 ;;=4^B35.4
 ;;^UTILITY(U,$J,358.3,15731,2)
 ;;=^119704
 ;;^UTILITY(U,$J,358.3,15732,0)
 ;;=B35.8^^88^869^140
 ;;^UTILITY(U,$J,358.3,15732,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15732,1,3,0)
 ;;=3^Dermatophytoses,Other
 ;;^UTILITY(U,$J,358.3,15732,1,4,0)
 ;;=4^B35.8
 ;;^UTILITY(U,$J,358.3,15732,2)
 ;;=^5000606
 ;;^UTILITY(U,$J,358.3,15733,0)
 ;;=B36.9^^88^869^312
 ;;^UTILITY(U,$J,358.3,15733,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15733,1,3,0)
 ;;=3^Superficial Mycosis,Unspec
 ;;^UTILITY(U,$J,358.3,15733,1,4,0)
 ;;=4^B36.9
 ;;^UTILITY(U,$J,358.3,15733,2)
 ;;=^5000611
 ;;^UTILITY(U,$J,358.3,15734,0)
 ;;=D69.0^^88^869^33
 ;;^UTILITY(U,$J,358.3,15734,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15734,1,3,0)
 ;;=3^Allergic Purpura
 ;;^UTILITY(U,$J,358.3,15734,1,4,0)
 ;;=4^D69.0
 ;;^UTILITY(U,$J,358.3,15734,2)
 ;;=^5002365
 ;;^UTILITY(U,$J,358.3,15735,0)
 ;;=B00.9^^88^869^161
 ;;^UTILITY(U,$J,358.3,15735,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15735,1,3,0)
 ;;=3^Herpesviral Infection,Unspec
 ;;^UTILITY(U,$J,358.3,15735,1,4,0)
 ;;=4^B00.9
 ;;^UTILITY(U,$J,358.3,15735,2)
 ;;=^5000480
 ;;^UTILITY(U,$J,358.3,15736,0)
 ;;=B02.9^^88^869^331
 ;;^UTILITY(U,$J,358.3,15736,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15736,1,3,0)
 ;;=3^Zoster w/o Complications
 ;;^UTILITY(U,$J,358.3,15736,1,4,0)
 ;;=4^B02.9
 ;;^UTILITY(U,$J,358.3,15736,2)
 ;;=^5000501
 ;;^UTILITY(U,$J,358.3,15737,0)
 ;;=D17.9^^88^869^90
 ;;^UTILITY(U,$J,358.3,15737,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15737,1,3,0)
 ;;=3^Benign Lipomatous Neop,Unspec
 ;;^UTILITY(U,$J,358.3,15737,1,4,0)
 ;;=4^D17.9
 ;;^UTILITY(U,$J,358.3,15737,2)
 ;;=^5002020
 ;;^UTILITY(U,$J,358.3,15738,0)
 ;;=E08.621^^88^869^137
 ;;^UTILITY(U,$J,358.3,15738,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15738,1,3,0)
 ;;=3^DM d/t Underlying Condition w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,15738,1,4,0)
 ;;=4^E08.621
 ;;^UTILITY(U,$J,358.3,15738,2)
 ;;=^5002534
 ;;^UTILITY(U,$J,358.3,15739,0)
 ;;=E09.621^^88^869^136
 ;;^UTILITY(U,$J,358.3,15739,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15739,1,3,0)
 ;;=3^DM d/t Drug/Chemical w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,15739,1,4,0)
 ;;=4^E09.621
 ;;^UTILITY(U,$J,358.3,15739,2)
 ;;=^5002576
 ;;^UTILITY(U,$J,358.3,15740,0)
 ;;=H05.011^^88^869^112
 ;;^UTILITY(U,$J,358.3,15740,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15740,1,3,0)
 ;;=3^Cellulitis of Right Orbit
 ;;^UTILITY(U,$J,358.3,15740,1,4,0)
 ;;=4^H05.011
 ;;^UTILITY(U,$J,358.3,15740,2)
 ;;=^5004560
 ;;^UTILITY(U,$J,358.3,15741,0)
 ;;=H05.012^^88^869^105
 ;;^UTILITY(U,$J,358.3,15741,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15741,1,3,0)
 ;;=3^Cellulitis of Left Orbit
 ;;^UTILITY(U,$J,358.3,15741,1,4,0)
 ;;=4^H05.012
 ;;^UTILITY(U,$J,358.3,15741,2)
 ;;=^5004561
 ;;^UTILITY(U,$J,358.3,15742,0)
 ;;=H05.013^^88^869^99
 ;;^UTILITY(U,$J,358.3,15742,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15742,1,3,0)
 ;;=3^Cellulitis of Bilateral Orbits
 ;;^UTILITY(U,$J,358.3,15742,1,4,0)
 ;;=4^H05.013
 ;;^UTILITY(U,$J,358.3,15742,2)
 ;;=^5004562
 ;;^UTILITY(U,$J,358.3,15743,0)
 ;;=I70.331^^88^869^51
 ;;^UTILITY(U,$J,358.3,15743,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15743,1,3,0)
 ;;=3^Athscl Bypass of Right Leg w/ Ulcer of Thigh
